Tue, Jun 22, 2021 2:00 PM – 3:00 PM EDT
Nearly 20% of Americans are diagnosed with a mental health condition every year. Yet, more than half of those don’t receive a treatment for their condition. Globally, neurological disorders are one of the leading causes of disability and death with few if any treatments available depending on the condition. Despite the high unmet need in behavioral and neurological disorders, drug development continues to be challenging. Real-world data, standardized outcomes measures, and advanced analytics offer the promise to accelerate research, access to treatments, and clinical outcomes in critical areas, such as depression, anxiety, ADHD, bipolar disorder, and multiple sclerosis.
This webinar explores:
– Using standardized outcomes measures to improve research and clinical care
– Accessing research-grade retrospective data for decision making
– Leveraging data networks to collect prospective research and to meet regulatory requirements
– Unlocking the potential of patient-reported and unstructured data for understanding outcomes
Presenter: Richard Gliklich, MD, CEO, OM1